amerisourcebergen corporation logo

AmerisourceBergen Corporation

COMPANY DETAILS

Company Name

AmerisourceBergen Corporation

Head Quarter

Chesterbrook, Pennsylvania, U.S.

Founders

Richard C. Gozon

CEO

Steven H. Collis

Inception Date

1979

Total assets

US$57.34 billion (2021)

History

Amerisource Bergen was formed by merging Amerisource Health Corporation and Bergen Brunswig Corporation in 2001. David Yost, the CEO of Amerisource, remained in the position after the companies merged. The Company AmerisourceBergen owns 26 pharmaceutical distribution centers in the Country U.S.

It has nine distribution centers in Canada, four specialty distribution centers in the U.S., and more than one million square feet of packaging production capacity in the U.K. and the U.S. With the addition of World Courier (it's the largest specialty courier company in the world); Amerisource Bergen became the company with 150 offices around the globe. In 2011, the company acquired intrinsic for $35 million and a premier source for an undisclosed amount. In July 2011, Steven Collis replaced Yost with the position of the Company's CEO.

The company bought MWIveterinary for $2.5 billion, and in October, they agreed to buy a drug company for PharMEDium for $2.58 billion. In 2018, Amerisource Bergen acquired H.D. Smith, the largest privately held national pharmaceutical wholesaler in the U.S. AmerisourceBergen is among several distributors contributing to the Opioid Epidemic by shipping excessive amounts of pain medication into the state. On June 29, the U.S. Department of Health and Human Services announced an unusual agreement with Gilead in which HHS agreed to Gilead's wholesale acquisition price. AmerisourceBergen controls about 20% of all the pharmaceuticals sold and distributed throughout the United States.

Also, it ranked 10th on the Fortune 500 list. Amerisource Bergen manages its pharmaceutical distribution business under four primary Units: AmerisourceBergen Drug Corporation, AmerisourceBergen Speciality Group, AmerisourceBergen Consulting Services, and World Courier. In 2016, Walgreen Boots Alliance Inc. announced to exercise of an option to buy 22.7 million shares of AmerisourceBergen stock. And thereby control approximately 15% of the company. Good Neighbour Pharmacy is an American retailers' cooperative network of more than 3,400 independently owned pharmacies. It has an affiliation with AmerisourceBergen and sponsors for "Thought Spot."


Market share and Current Stage

With an estimated 42,000 employees, Company AmerisourceBergen includes a significant market share in the three industries: wholesale trade, drug, cosmetic, and toiletry wholesaling, wholesale trade, and more. Their largest share can be seen in the pharmaceutical wholesaling sector. Here, they account for an estimated 20.3% of total industry revenue. Thus they are considered a rising star even while displaying a lower market share but more robust profit and revenue growth.

This pharmaceutical sourcing and distribution service is well-known for offering pharmaceutical products, business solutions, and value-driving services that tend to improve access to care. In Jan 2022, AmerisourceBergen, along with McKesson, Cardinal Health, and Jonson & Jonson, agreed to pay $26 billion to settle with all.

In Quarter 3 2022, the Company AmerisourceBergen Corp's revenue jumped to 3.84% since last year's same period to $61174.15M. Regarding quarterly growth, the Company has generated approximately a 1.85% jump in its revenue in the last three months.

Net Profit Margins

The Company's net profit fell -35.15% since last year's same period to 0.485 in Quarter 3, 2022. When we see on a quarterly basis, the Company has generated around -a 28.89% fall in its net profit margins in the last three months.

PE Ratio

After Q3 2022, the Company's price-to-earnings ratio stands at 20.55.

Competitor Analysis

AmerisourceBergen is working to connect pharmaceutical manufacturers and healthcare providers. The top competitors and similar Companies of AmerisourceBergen are CWS Group, Owens & Minor, Henry Schein, Cardinal Health, and McKesson. When we compare the results to AmerisourceBergen's competitors, the Company reported a Total Revenue decrease in the three quarter of the 2022 year on year by 0 %, slower than the combined decrease of the Company's competitors by -17.47 %, recorded in the same quarter.

Net Income Comparison

The Company recorded a net loss as well as most of its competitors.https://csimarket.com/stocks/compet_glance.php?code=ABC


FAQ'S

Opioid-based products are a small fraction of what we distribute. It is a very small part of AmerisourceBergen's total business. Distributors have small profit margins, so the company has invested heavily in systems and controls to manage all the products.
The largest shareholder of AmerisourceBergen is the Walgreens Boots Alliance. They hold nearly 30% of the market share. Ornella Barra is a board member of AmerisourceBergen. He is also a co-chief operating officer at Walgreen boosts Alliance.
Steven H. Collis is the CEO, President, and Chairman of the AmerisourceBergen Corporation. He was elected chairman in 2016 and President and CEO in 2011.
AmerisourceBergen consists of over 40,000 employees who are continuously improving healthcare services. Many people work in a wide range of roles across our business units.
AmerisourceBergen is a pharmaceutical company that serves North America and the United Kingdom. They offer specialty pharmacies, retail pharmacies, home healthcare companies, and hemophilia centers in 100% of U.S. Hospitals.
AmerisourceBergen Corporation is a global healthcare solutions leader. The company is currently in the top 10 rankings of the Fortune 500.

Affiliation Disclosure

We are an independent information and service provider and may offer a charge/subscription option for premium services, although free service/warranty may be available by your vendor. We are in no way associated with any company or brand and do not promote them either. All the brand and company names used on our website at “consultwiki.com” are for informational purposes only.